About this trial
This randomized controlled trial will evaluate whether a brief preoperative virtual reality intervention reduces anxiety and improves early recovery in adults undergoing elective gynecological surgery. Approximately 140 participants will be randomly assigned in a 1:1 ratio to either virtual reality in addition to usual care or usual care alone. The virtual reality intervention will consist of approximately 10-20 minutes of an immersive relaxation experience before surgery. The primary outcome is the change in preoperative anxiety measured before and after the intervention. Secondary outcomes include postoperative quality of recovery, pain, opioid consumption, postoperative nausea and vomiting, and early recovery-related healthcare outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 years or older.
Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.
Disqualifiers
Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
Active substance use disorder or active misuse of alcohol or illicit drugs.
Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.
Trial design
Parallel
Treatments tested in this trial
Preoperative Virtual Reality
BehavioralA single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area. Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset. The intervention is intended to provide relaxation, comfort, and distraction before surgery.
Usual Perioperative Care
Other interventionParticipants receive standard perioperative care according to local clinical routines. No preoperative virtual reality session is provided during the corresponding intervention period.
Treatment groups
Trial outcomes
Primary outcomes
Quality of Postoperative Recovery Measured With QoR-15
Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
Secondary outcomes
Change in Preoperative Anxiety
Anxiety will be assessed before and after the preoperative intervention period using the anxiety measure specified in the study protocol. Higher scores indicate greater anxiety.
Postoperative Pain Intensity
Postoperative pain will be assessed using a numerical rating scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Postoperative Opioid Consumption
Total postoperative opioid consumption will be calculated and converted to intravenous morphine milligram equivalents.
Incidence of Postoperative Nausea and Vomiting
Number and proportion of participants experiencing nausea, vomiting, or both during the postoperative period.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: